Financial Health Snapshot
What does Axon Enterprise’s latest financial snapshot show?
Axon Enterprise’s financial health looks Strong. The strongest factor is revenue growth and recurring demand, while the main concern is the negative free cash flow growth signal and tariff pressure.
For the latest verified fiscal period, 2026-03-31, this snapshot blends growth, profitability, cash generation, balance-sheet capacity, and capital efficiency. The mix points to a company with strong scale and liquidity, but cash conversion and margin pressure still deserve attention.
For deeper analysis first, start with free cash flow because it best tests whether Axon Enterprise can turn growth into durable cash. Exploring Axon Enterprise, Inc. (AXON) Investor Profile: Who's Buying and Why?
Revenue Quality
Are Axon Enterprise, Inc. revenues and earnings high quality?
Strong. The clearest confirmation is the combination of $130B ARR, 12500% net revenue retention, and $1440B future contracted bookings, which points to recurring demand. The main divergence is that hardware growth can still add lumpiness, so cash conversion still matters.
Axon Enterprise, Inc. is showing more than just fast revenue growth; the key question is whether that growth is repeatable and profitable. Investors compare revenue durability with operating income, net income, and EPS because sales can rise faster than true earnings, and quality is better when profits and per-share results improve too. For a related ownership angle, Exploring Axon Enterprise, Inc. (AXON) Investor Profile: Who's Buying and Why? helps frame who may support that demand.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $278B, 3347% year-over-year, FY 2025 | Prior comparable period not provided | Unclear; supported by recurring software scale and hardware-related growth | Some growth looks repeatable, but the source mix still needs monitoring |
| Operating Income | $3524M, 2026-03-31 | Prior comparable period not provided | Unavailable versus revenue; direction is positive in the latest period | Profitability is improving, but operating leverage cannot be fully tested here |
| Net Income | $16931M, 2026-03-31 | Prior comparable period not provided | Needs review of operating, interest, tax, and unusual-item effects | Final earnings are strong on the face of it, but quality depends on non-operating items |
| Diluted EPS | $205, 2026-03-31 | Prior comparable diluted EPS not provided | Share-count effect cannot be verified from the data provided | Per-share results improved, but investors still need to check dilution and cash conversion |
How durable are Axon Enterprise, Inc. revenues?
Very durable on the recurring side. The strongest visibility comes from software subscriptions, 12500% net revenue retention, and $1440B contracted bookings; the biggest limitation is that backlog and ARR are not current revenue.
- Demand Quality: Recurring software subscriptions give visibility, while hardware refresh cycles add some cyclicality.
- Pricing and Volume: The split is not fully provided; software recurrence is clearer than any price or unit detail for devices.
- Diversification: Revenue is split between software and connected devices, but customer and geography concentration are not fully provided.
That mix makes profitability and cash conversion the next test.
Cash Conversion
Do Axon Enterprise’s profits turn into cash efficiently?
Not cleanly right now: reported profit is strong, but operating and free cash flow both weakened sharply in the latest period, so cash conversion does not fully confirm earnings. Margin pressure from global tariffs and a heavier hardware mix in Connected Devices also points to less efficient conversion.
Axon Enterprise showed $47729M gross profit, $3524M operating income, and $16931M net income for 2026-03-31, but those earnings sit alongside $2864M interest expense, $18895M R&D, and $25309M SG&A. Gross margin reflects product economics, operating margin shows overhead leverage, and net margin includes financing and tax effects. The link between reported profit and cash is weaker when capex stays high, with 2026 CapEx projected at $17000M to $18000M.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | 2026-03-31: not supplied | FY 2025: not supplied | Global tariffs and a higher hardware mix in Connected Devices pressured economics. | Product profitability appears under some cost pressure. |
| Operating Margin | 2026-03-31: not supplied | FY 2025: not supplied | $3524M operating income against heavy $18895M R&D and $25309M SG&A points to sizable operating spend. | Scale is not yet translating into strong operating efficiency. |
| Net Margin | 2026-03-31: not supplied | FY 2025: not supplied | $16931M net income was reduced by $2864M interest expense and $3091M income tax expense. | Final profitability exists, but it is not a pure measure of cash generation. |
| Operating Cash Flow | 2026-03-31: -11451% | FY 2025: not supplied | Directional warning only; receivables growth of -894% and inventory growth of 1937% signal working-capital strain. | Accounting earnings are not converting smoothly into operating cash. |
| Free Cash Flow | 2026-03-31: -13516% | FY 2025: not supplied | Projected CapEx of $17000M to $18000M adds a reinvestment burden. | Less cash is left for debt reduction, buybacks, or new investment. |
What most affects Axon Enterprise’s cash conversion?
Working capital and reinvestment are the main issues: receivables, inventory, and projected CapEx are weighing on cash more than reported earnings suggest.
- Main Driver: Working-capital pressure and high CapEx look structural near term, not just a one-quarter issue.
- Evidence Gap: The data does not show exact quarterly cash flow dollars or segment-level cash conversion.
- Metric to Monitor: Follow operating cash flow and inventory growth next.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. For a broader business history view, see Axon Enterprise, Inc. (AXON): History, Ownership, Mission, How It Works & Makes Money.
Liquidity and leverage
Does Axon Enterprise have enough liquidity and debt capacity to support its obligations and investment needs?
Mixed. Axon Enterprise has a strong near-term cash cushion, but its debt load and heavy intangible assets make flexibility less clean than cash alone suggests. The main protection is $71892M in cash and short-term investments; the main concern is $183B of long-term debt alongside a large goodwill balance.
Cash by itself is not enough. The full picture has to include working capital, asset quality, debt service, solvency, liquidity, and refinancing risk together. Axon Enterprise shows meaningful near-term resources, but investors should weigh those against the size of liabilities, the quality of non-cash assets, and any refinancing pressure if credit conditions tighten.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | Cash and Cash Equivalents: $45892M; Short Term Investments: $26000M; Cash and Short Term Investments: $71892M; Total Current Assets: $274B; Total Current Liabilities: $121B | Strong | Near-term obligations appear covered, with room to fund operations and investment without immediate liquidity strain. |
| Total and Net Debt | Long Term Debt: $183B; cash and short-term investments: $71892M; net debt can be inferred only cautiously because the full debt stack is not supplied | Mixed | Leverage is meaningful, so debt does not block flexibility, but it does reduce room for error. |
| Debt Service and Refinancing | No debt service coverage ratio or full maturity schedule is supplied; a 2024 financial restatement tied to balance sheet classification of $69000M in 050% convertible senior notes due 2027 is a reporting watch item | Mixed | Interest and refinancing capacity cannot be fully measured here, so investors should watch disclosures and any funding needs closely. |
| Asset Quality | Net Receivables: $87034M; Inventory: $40801M; Deferred Revenue: $69042M; Goodwill: $189B; Intangible Assets: $29507M | Mixed | Receivables, inventory, and especially goodwill and intangibles deserve attention because they affect collection risk and impairment exposure. |
| Liabilities and Equity | Total Liabilities: $353B; Total Stockholders Equity: $353B; Total Assets: $707B | Mixed | The capital base is large, but liabilities are also large, so loss-absorption is adequate rather than exceptional. |
What balance-sheet risk matters most for Axon Enterprise?
The biggest risk is leverage plus asset quality: $183B of long-term debt and $189B of goodwill can pressure flexibility more than short-term liquidity.
- Current Exposure: Total Current Assets: $274B versus Total Current Liabilities: $121B.
- Protection: Cash and Short Term Investments: $71892M plus Total Stockholders Equity: $353B.
- Warning Signal: Watch the 2024 restatement, debt classification, and any weakening in refinancing access or asset values.
Capital Efficiency
Is Axon Enterprise, Inc. reinvesting capital efficiently?
Axon Enterprise, Inc. looks Mixed. Internal cash appears partly sufficient, but not fully enough to cover all reinvestment needs because spending is still heavy on R&D, CapEx, and acquisitions.
Return analysis has to include leverage, asset intensity, capital expenditure, working capital, and outside funding needs. Axon Enterprise, Inc. is still in a build-out phase, so high reinvestment can support growth even when near-term returns are harder to measure cleanly.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | ROIC is not supplied for the latest period, so it should not be calculated here. | Heavy R&D and scaling spending can support future returns, but the current efficiency result cannot be verified from the supplied data. | Invested capital may be building future operating value, but the proof is not yet visible in a supplied ROIC figure. |
| ROE and ROA | ROE and ROA are not supplied, so no clean period comparison is available. | ROE could be lifted by leverage, while ROA is more affected by asset intensity; neither can be treated as strong without numbers. | Shareholder return quality and asset efficiency remain uncertain until those metrics are disclosed. |
| Maintenance and Growth Investment | Research And Development Expenses: $18895M for 2026-03-31, with Rdexpense Growth: 4101%; workforce increases in R&D and SG&A support AI initiatives and international expansion. 2026 CapEx projected in the range of $17000M to $18000M for manufacturing and infrastructure scaling. | The evidence points to aggressive growth investment, not just maintenance spending. | Capital is being used to expand product, platform, and delivery capacity, which can raise future scale if execution holds. |
| Internal Funding Capacity | Funding is also being pushed by acquisitions including Carbyne for $62500M in cash, plus Prepared, Dedrone, and Fusus. | This looks partly internally funded, but still dependent on continued cash generation and disciplined execution. | Acquisition-led expansion can strengthen the platform, but it raises the bar for integration and cash discipline. |
Are Axon Enterprise, Inc.'s returns on capital sustainable?
Sustainability looks tied to product mix and recurring platform demand. The main weakness is heavy reinvestment, plus stock-based compensation expense for FY 2025 estimated at $58000M to $63000M, which can pressure per-share returns.
- Operating Source: R&D, AI initiatives, and international expansion should support margin mix if adoption stays strong.
- Funding Requirement: The largest verified capital needs are R&D, 2026 CapEx projected in the range of $17000M to $18000M, and acquisition spending.
- Durability Test: Returns weaken if cash flow does not keep pace with reinvestment or if stock-based compensation keeps diluting per-share value.
Financial Resilience
How resilient is Axon Enterprise, and which warning signs matter most?
Axon Enterprise looks Mixed. Its main buffer is recurring revenue and contracted demand, while the most important verified warning sign is tariff-driven margin pressure alongside a heavier hardware mix in Connected Devices, which can squeeze gross profit before cash generation catches up.
Axon Enterprise has room to absorb stress because demand is supported by recurring revenue, Net Revenue Retention of 12500%, Total Future Contracted Bookings of $1440B, and liquidity. Still, resilience is not the same as immunity. If hardware costs rise faster than pricing, or if cash conversion weakens, the company’s ability to fund growth, debt service, and product investment gets tighter.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Tariff-driven cost pressure and a larger Connected Devices hardware mix can reduce gross profit, weaken operating leverage, and limit cash available for growth or debt capacity. Gross Profit Growth: 346% and Gross Profit: $47729M for 2026-03-31 show the current scale to protect. | Recurring revenue, contracted bookings, and pricing power in software and services help offset hardware volatility. | A weaker gross profit trend, slower gross profit growth, or margin compression would confirm deterioration. |
| Working-Capital or Investment Pressure | Inventory growth of 1937% and projected 2026 CapEx of $17000M to $18000M could absorb cash, especially if working capital rises faster than operating income. | Liquidity and recurring cash generation help fund operations internally when conversion stays stable. | Actual operating cash flow turning weaker, alongside rising inventory or capex, would signal added strain. |
| Interest or Refinancing Pressure | Even without a stated debt burden here, lower free cash flow can reduce financing flexibility and make future funding less comfortable if rates rise or markets tighten. | Liquidity and contracted demand reduce near-term refinancing stress. | Falling cash balances, tighter credit access, or declining free cash flow would show rising pressure. |
Which financial warning signs should investors monitor at Axon Enterprise?
The strongest signals are gross profit margin pressure, operating cash flow deterioration, and dilution from stock-based compensation. The first two would be confirmed deterioration; dilution is a future risk unless per-share results improve faster than share count growth.
Tariff and Hardware Mix Pressure
Tariffs and a heavier Connected Devices mix can hit cost of revenue first, then gross profit. The offset is recurring revenue and bookings, but investors should watch gross profit growth and gross profit for any slowdown from the 346% and $47729M levels.
Cash Conversion Swing
Operating Cash Flow Growth: -11451%, Free Cash Flow Growth: -13516%, and Inventory Growth: 1937% point to volatility in cash conversion. The mitigation is liquidity, but the next metric to watch is actual operating cash flow.
Stock-Based Compensation Dilution
FY 2025 stock-based compensation expense is estimated at $58000M to $63000M, which can dilute per-share value even if revenue grows. Compare that with Weighted Average Shares Outstanding: 8015M and Weighted Average Diluted Shares Outstanding: 8248M for 2026-03-31.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help organize Axon Enterprise’s resilience, risks, and defenses clearly. For a deeper read on strategy, see Mission Statement, Vision, & Core Values (2026) of Axon Enterprise, Inc. (AXON).
Mixed Scorecard
What does Axon Enterprise, Inc. financial health mean for investors?
Axon Enterprise, Inc. rates Mixed overall. Growth and liquidity are the biggest strengths, while dilution and margin pressure are the biggest weaknesses. The most important condition for the investment case is whether recurring growth keeps outpacing cash conversion pressure and stock-based compensation.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | Revenue growth of 3400% in Q1 2026, FY 2025 Revenue of $278B, ARR of $130B, Net Revenue Retention of 12500%, and Total Future Contracted Bookings of $1440B show strong recurring demand. |
| Profitability and Cash | Mixed | FY 2025 Adjusted EBITDA of $70000M+ and an Adjusted EBITDA Margin of 2550% are solid, but tariffs, hardware mix, Operating Cash Flow Growth of -11451%, and Free Cash Flow Growth of -13516% hurt cash quality. |
| Balance Sheet and Liquidity | Strong | Cash, short-term investments, and current assets support flexibility, and the earlier Net Cash Position of $35600M helps. Long Term Debt of $183B and the convertible-note restatement remain watch items. |
| Capital Efficiency | Mixed | R&D, M&A, and CapEx support growth, but stock-based compensation expense for FY 2025 estimated at $58000M to $63000M can dilute per-share returns and slow value creation. |
| Financial Resilience | Mixed | Backlog and recurring revenue provide a buffer, but tariffs, weak cash conversion, and dilution pressure the profile. Resilience looks adequate, not bulletproof. |
- What Supports the Thesis: Strong recurring growth, large contracted bookings, and a net cash position give Axon Enterprise, Inc. room to keep investing.
- What Challenges the Thesis: Stock-based compensation, tariff pressure, and weak cash conversion could limit per-share upside.
- What to Monitor: Net Revenue Retention: 12500%, Operating Cash Flow Growth: -11451%, and stock-based compensation expense for FY 2025 estimated at $58000M to $63000M.
For forecasts, scenarios, and valuation work, the key question is whether growth, margins, and cash conversion stay aligned; for a broader ownership lens, see Exploring Axon Enterprise, Inc. (AXON) Investor Profile: Who's Buying and Why?.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
Why does net revenue retention matter for health?
Net revenue retention shows whether existing customers expand spending after churn and contraction Axon Enterprise reported Net Revenue Retention: 12500%, which supports revenue durability because existing customer relationships appear to grow It should still be checked against new bookings, backlog conversion, and margin quality
Can Axon fund growth without more debt?
Axon Enterprise has meaningful liquidity, including Cash And Short Term Investments: $71892M at 2026-03-31 and earlier Cash and Equivalents: $240B at September 30, 2025 However, acquisitions, R&D, CapEx, and working capital can still require careful funding choices
How does stock-based compensation affect per-share returns?
Stock-based compensation is a non-cash expense, but it can increase dilution if awards become shares Axon Enterprise estimated stock-based compensation expense for FY 2025 at $58000M to $63000M, so investors should compare business growth with changes in diluted shares over time
What does adjusted EBITDA margin show about resilience?
Adjusted EBITDA margin shows operating profit before selected costs, interest, taxes, depreciation, and amortization Axon Enterprise reported Adjusted EBITDA Margin: 2550% for FY 2025, which supports resilience, but it does not replace net income, operating cash flow, or free cash flow analysis
Why separate cash flow from net income?
Net income measures accounting profit, while cash flow shows actual cash generated or used by operations and investments Axon Enterprise reported Net Income: $16931M at 2026-03-31, but Operating Cash Flow Growth: -11451% and Free Cash Flow Growth: -13516% show why conversion needs separate monitoring